1月3日, 南向资金增持金斯瑞生物科技407.00万股。截止当日收盘,港股通共持有金斯瑞生物科技55031.98万股,占流通股25.66%。港股通增持金额前五个股分别为中芯国际、中国移动、小米集团-W、优必选、工商银行。金斯瑞生物科技近5个交易日下跌0.50%,港股通累计增持391.59万股;近20个交易日下跌9.47%,港股通累计增持2241.72万股。|1月3日港股通(深)十大成交榜|||#|...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.